Notice of Results

RNS Number : 9463S

Syncona Limited

11 November 2019

 

11 November 2019

Notice of Interim Results

Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life sciences, expects to announce its interim financial results for the six months ended 30 September 2019 on Thursday 21 November 2019.

A presentation for analysts will take place at 9.00am GMT and a webcast of the presentation will be available on the Company's website at https://www.synconaltd.com/ or https://webcast.openbriefing.com/syncona-interim2019/

To join via conference call, please dial:

United Kingdom:	0800 640 6441
United Kingdom (Local):	020 3936 2999
All other locations:	[phone]
Access code:	379204

[ENDS]

Enquiries

Syncona Ltd

Siobhan Weaver / Annabel Clay 

Tel: [phone]

 FTI Consulting

Brett Pollard / Ben Atwell / Natalie Garland-Collins

Tel: [phone]

About Syncona

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

 

END

 

 

NORCKDDQFBDKDDD